You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Adaptix Interbody System
Adaptix™ interbody system offers a robust design for increased strength,1 easy insertion, subsidence resistance,2,3 and incorporates Titan nanoLOCK™ surface technology for proven bone growth.*Contact Us
The Adaptix™ titanium spinal cage combines the trusted features of the Capstone™ spinal system, with several design enhancements.
1. Honeycomb Structure
2. Open Graft Windows
3. Dolphin Nose
4. Lateral Windows
5. Implant Width of 10mm
Titan nanoLOCK™ surface technology is created through a subtractive manufacturing process that removes material to enable a proprietary blend of surfaces at the macro, micro, and nano levels on every surface of the implant.
Inspired by nature, this surface technology uses "biomimicry" of osteoclastic pit geometry to mimic structures involved in the bone remodeling process.DOWNLOAD BROCHURE
Driven by science, Titan nanoLOCK™ surface technology emerged from a research-first approach to development. Multiple peer-reviewed in vitro studies resulted in Titan nanLOCK surface technology being the first to demonstrate the elements to be considered in nanotechnology as outlined by the FDA.4
Download the latest peer-reviewed articles:
The navigated Adaptix™ interbody system integrates with the StealthStation™ navigation and O-arm™ imaging systems to enable pre-surgical planning, real-time navigation, and other benefits including virtual sizing of the spinal implant, 3D implant placement visualization, and confirmation of implant placement using the Surgical Synergy™ workflow.
Inspired by nature, this technology incorporates a proprietary blend of surfaces. Learn more about Titan nanoLOCK™ surface technology.EXPLORE NANOLOCK
Comparison of Adaptix and Capstone testing per ASTM F2077and ASTM F2267
Based on surface area measurement
Based on engineering principles
FDA Guidance, Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology
Based on six peer-reviewed, published in vitro studies on Titan surface technology:
I. Matteson, J.L., Greenspan, D.C., Tighe, T.B., Gilfoy, N., Stapleton, J.J. Assessing the hierarchical structure of titanium implant surfaces. J Biomed Mater Res B. [In Press] EPub29 May 2015.
II. Olivares-Navarrete, R., HyzyS.L., Gittens, R.A., Schneider, J.M., Haithcock, D., Ullrich, P., Schwartz, Z., Boyan, B.D. Rough titanium alloys regulate osteoblast production of angiogenic factors. Spine J. 2013 Nov; 13(11):1563-70.
III. Gittens, R.A., Olivares-Navarrete, R., Schwartz, Z., Boyan, B.D. Implant osseointegration and the role of microroughness and nanostructures: Lessons for spine implants. Acta Biomater 2014 Aug; 10(8): 3363-3371.
IV. Olivares-Navarrete, R., HyzyS.L., Gittens, R.A., Berg, M.E., Schneider, J.M., Hotchkiss, K., Schwartz, Z., Boyan, B. D. Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. Ann Biomed Eng. 2014 Dec; 42(12): 2551-61.
V. Olivares-Navarrete, R., HyzyS.L., Slosar, P.J., Schneider, J.M., Schwartz, Z., Boyan, B.D. Implant materials generate different peri-implant inflammatory factors: PEEK promotes fibrosis and micro-textured titanium promotes osteogenic factors. Spine. 2015 Mar; 40(6): 399-404.
VI. Banik, B., Riley, T., Platt, C., Brown, J. Human mesenchymal stem cell morphology and migration on microtextured titanium. Front Bioeng Biotechnol. 2016 May; 4(41) doi: 10.3389/fbioe.2016.00041.